Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02MVA
|
|||
| Former ID |
DIB013451
|
|||
| Drug Name |
NI-0701
|
|||
| Synonyms |
Alpha-RANTES; RANTES ligand inhibitor (iv, autoimmune/inflammatory disease), NovImmune
Click to Show/Hide
|
|||
| Indication | Autoimmune diabetes [ICD-11: 5A10] | Phase 1 | [1] | |
| Company |
NovImmune SA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01255501) First in Human Study of NI-0701 in Healthy Volunteers. U.S. National Institutes of Health. | |||
| REF 2 | Handbook of Therapeutic Antibodies. Stefan D bel, Janice M. Reichert, 2014. Page(1021). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.